arXiv Science⌕ Search

arXiv · 2611.11008

Cause-specific structural nested cumulative survival time models for competing risks, with application to the Antibody Mediated Prevention trials

Abstract

The Antibody Mediated Prevention (AMP) trials randomized participants to VRC01, a broadly neutralizing antibody, or placebo; the primary analysis estimated prevention efficacy against overall HIV-1 acquisition and against acquisition of VRC01-sensitive strains. All participants were offered daily oral pre-exposure prophylaxis (PrEP), and PrEP uptake in a trial may differ substantially from uptake in other settings. It is therefore of interest to estimate the effect of oral PrEP on acquisition of VRC01-sensitive and VRC01-insensitive strains, as well as the counterfactual cumulative incidence of such acquisition under no or limited PrEP uptake. To address these questions, we extend the structural nested cumulative survival time model (SNCSTM), a causal survival model for time-varying treatments, to a cause-specific version. We show that the cause-specific SNCSTM is closely related to the Fine--Gray subdistribution hazard model, and we study identification under two frameworks. The first, based on sequential ignorability, applies when the time-varying treatment is distinct from the randomized assignment, as with oral PrEP use in AMP. The second, based on an instrumental variable, applies when the time-varying treatment represents compliance with the randomized assignment, and it accommodates unmeasured confounding between the time-varying treatment and event time. Under both frameworks, we propose consistent and asymptotically normal estimators of the structural parameters. We apply the methods to HVTN 704/HPTN 085, one of the two AMP trials, to estimate the effects of oral PrEP use and of VRC01 infusions administered every 8 weeks on acquisition of VRC01-sensitive and VRC01-insensitive HIV-1 strains. We also estimate the counterfactual strain-specific cumulative incidence curves under no oral PrEP use and under full adherence to the scheduled VRC01 infusions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Yuxiao Li, Yuhao Deng, Bo Zhang. 2026-11-07. Cause-specific structural nested cumulative survival time models for competing risks, with application to the Antibody Mediated Prevention trials. https://arxiv.science/abs/2611.11008

Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite arXiv Science by Indiciae: BibTeX · RIS.

KEEP EXPLORING

Related papers

Statistical Performance Guarantee for Subgroup Identification with Generic Machine Learning

Across a wide array of disciplines, many researchers use machine learning (ML) algorithms to identify a subgroup of individuals who are likely to benefit from a treatment the most (``exceptional responders'') or those who are harmed by it. A common approach to this subgroup identification problem consists of two steps. First, researchers estimate the conditional average treatment effect (CATE) using an ML algorithm. Next, they use the estimated CATE to select those individuals who are predicted to be most affected by the treatment, either positively or negatively. Unfortunately, CATE estimates are often biased and noisy. In addition, utilizing the same data to both identify a subgroup and estimate its group average treatment effect results in a multiple testing problem. To address these challenges, we develop uniform confidence bands for estimation of the group average treatment effect sorted by generic ML algorithm (GATES). Using these uniform confidence bands, researchers can identify, with a statistical guarantee, a subgroup whose GATES exceeds a certain effect size, regardless of how this effect size is chosen. The proposed methodology uses random treatment assignment, random sampling of units, and continuity and moment conditions, without requiring consistency or monotonicity of the ML score. We derive a Wiener representation of the estimation error, with corrections for the empirical subgroup threshold and the fixed treatment sample size. Estimating this representation gives asymptotically exact uniform coverage using Gaussian draws, without refitting the ML model. We also develop uniform bands for mean-adjusted treatment effects and other evaluation metrics. A simulation design and an application to a clinical trial of late-stage prostate cancer illustrate the subgroup identification problem.

stat.ME↗

Collaborative Optimal Design of Controlled Experiments with Subject Covariates

Modern experimental design problems often encounter multiple controlled experiments with subjects participating in more than one experiment. It is of interest to consider the optimal design of allocating subjects to treatment or control for these experiments especially when subject covariate information is available. In this work, we propose an optimal allocation method to enable accurate estimates of treatment effects for all experiments. Deriving the precision matrix of the treatment effects and using D-optimality as our allocation criterion, we demonstrate the advantage of collaboratively designing and analyzing multiple experiments over traditional independent design and analysis, and propose efficient algorithms to design construction of the D-optimality problem for collaborative experiments. The performance of the proposed methods is examined by simulation studies and a case study involving online education experimentation.

stat.ME↗

Parameter-Specific Bias Diagnostics in Random-Effects Panel Data Models

The Hausman specification test assesses the random-effects specification by comparing random-effects and fixed-effects estimators. This note uses the diagnostic of Karl and Zimmerman (2021) to give a coefficient-specific sensitivity summary from one fitted mixed model. The diagnostic measures alignment between fitted random effects and the weights used to estimate a coefficient or contrast. Its value need not equal finite-sample bias: fitted effects are shrunken, and response-dependent covariance estimates introduce an additional weighted-error term. We explain this distinction, describe simulations that refit the covariance parameters and retain the latent-effect and weighted-error contributions, and illustrate the calculations with gasoline-demand data and a multiple-membership value-added model. Connecting the diagnostic to established generalized least squares sensitivity analysis, including Vasnev's (2010) balanced-panel results, we identify it as the negative derivative of a coefficient or contrast with respect to the log scale of the random-effects covariance. With fitted covariance shapes held fixed, integrating the diagnostic over this log scale, upward from the fitted model, gives the random-effects estimate minus the fixed-effects estimate for a contrast estimable under both models. We also discuss conditioning on stochastic regressors and the additional assumptions needed for calibrated inference.

stat.ME↗